See more : Solara Active Pharma Sciences Limited (SOLARA.NS) Income Statement Analysis – Financial Results
Complete financial analysis of JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (JSP.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Albert David Limited (ALBERTDAVD.NS) Income Statement Analysis – Financial Results
- RattanIndia Enterprises Limited (RTNINDIA.BO) Income Statement Analysis – Financial Results
- Kim Loong Resources Berhad (5027.KL) Income Statement Analysis – Financial Results
- CSL Finance Limited (CSLFINANCE.BO) Income Statement Analysis – Financial Results
- Gold Reserve Inc. (GDRZF) Income Statement Analysis – Financial Results
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (JSP.BK)
About JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. provides contract manufacturing services for dietary supplements, cosmetics, herbs, nutritional supplements, and medicines in Thailand. It also provides research and development, packaging, pharmaceutical, and dietary supplement registration services, as well as offers cleaning products, such as hand sprays and pharma sanitizers. The company was incorporated in 2005 and is based in Bangkok, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 575.58M | 428.46M | 422.34M | 455.64M | 360.69M | 348.88M | 437.48M |
| Cost of Revenue | 431.10M | 305.84M | 277.97M | 310.02M | 249.25M | 251.24M | 319.62M |
| Gross Profit | 144.47M | 122.61M | 144.37M | 145.63M | 111.44M | 97.64M | 117.87M |
| Gross Profit Ratio | 25.10% | 28.62% | 34.18% | 31.96% | 30.90% | 27.99% | 26.94% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 131.01M | 93.25M | 72.87M | 63.39M | 63.37M | 47.27M | 44.69M |
| Selling & Marketing | 21.70M | 47.18M | 26.48M | 30.72M | 11.37M | 24.35M | 27.14M |
| SG&A | 152.70M | 140.43M | 99.35M | 94.11M | 74.75M | 70.72M | 74.11M |
| Other Expenses | -8.23M | -2.76M | -3.28M | -3.72M | -2.43M | 0.00 | 0.00 |
| Operating Expenses | 144.47M | 137.67M | 96.07M | 90.39M | 72.31M | 70.72M | 74.11M |
| Cost & Expenses | 584.30M | 443.51M | 374.04M | 400.40M | 321.56M | 321.96M | 393.73M |
| Interest Income | 0.00 | 7.30M | 10.40M | 11.44M | 119.51K | 13.34M | 12.84M |
| Interest Expense | 13.00M | 7.30M | 10.40M | 11.44M | 12.97M | 0.00 | 0.00 |
| Depreciation & Amortization | 46.71M | 26.90M | 22.23M | 21.40M | 15.95M | 13.14M | 12.71M |
| EBITDA | 96.68M | 34.71M | 62.89M | 72.52M | 55.08M | 43.43M | 59.14M |
| EBITDA Ratio | 16.80% | 2.56% | 16.70% | 16.97% | 15.27% | 11.48% | 12.91% |
| Operating Income | 1.31K | -15.06M | 48.30M | 53.24M | 39.13M | 26.91M | 43.76M |
| Operating Income Ratio | 0.00% | -3.51% | 11.44% | 11.68% | 10.85% | 7.71% | 10.00% |
| Total Other Income/Expenses | 36.97M | -466.41K | -10.87M | -13.56M | -12.85M | -13.34M | -12.84M |
| Income Before Tax | 36.97M | -21.44M | 37.43M | 39.68M | 30.09M | 16.87M | 33.52M |
| Income Before Tax Ratio | 6.42% | -5.00% | 8.86% | 8.71% | 8.34% | 4.84% | 7.66% |
| Income Tax Expense | 9.31M | -3.96M | 7.74M | 8.59M | 6.52M | 4.48M | 3.91M |
| Net Income | -1.27M | -17.48M | 29.69M | 31.08M | 23.57M | 12.39M | 29.60M |
| Net Income Ratio | -0.22% | -4.08% | 7.03% | 6.82% | 6.53% | 3.55% | 6.77% |
| EPS | 0.00 | -0.04 | 0.08 | 0.07 | 0.06 | 0.03 | 0.07 |
| EPS Diluted | 0.00 | -0.04 | 0.08 | 0.07 | 0.06 | 0.03 | 0.07 |
| Weighted Avg Shares Out | 469.11M | 455.00M | 360.48M | 426.00M | 426.00M | 426.00M | 426.00M |
| Weighted Avg Shares Out (Dil) | 469.11M | 455.00M | 360.48M | 426.00M | 426.00M | 426.00M | 426.00M |
Source: https://incomestatements.info
Category: Stock Reports